The biochemical differentiation of Enterobacter sakazakii genotypes by Iversen, Carol et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
The biochemical differentiation of Enterobacter sakazakii genotypes
Carol Iversen1,4, Mike Waddington2, Jim J Farmer III3 and 
Stephen J Forsythe*1
Address: 1School of Biomedical and Natural Sciences, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS, UK, 2Accugenix, 223 
Lake Drive, Newark, DE 19702, USA, 3Silver Hill Associates, 1781 Silver Hill Rd, Stone Mountain, GA 30087, USA and 4Quality and Safety 
Assurance Department, Nestlé Research Center, PO Box 44, CH 1000 Lausanne 26, Switzerland
Email: Carol Iversen - carol.iversen@hotmail.co.uk; Mike Waddington - MikeWaddington@accugenix.com; 
Jim J Farmer - jimfarmer812@earthlink.net; Stephen J Forsythe* - stephen.forsythe@ntu.ac.uk
* Corresponding author    
Abstract
Background:  Enterobacter sakazakii is an emergent pathogen that has been associated with
neonatal infections through contaminated powdered infant milk formula. The species was defined
by Farmer et al. (1980) who described 15 biogroups according to the biochemical characterization
of 57 strains. This present study compares genotypes (DNA cluster groups based on partial 16S
rDNA sequence analysis) with the biochemical traits for 189 E. sakazakii strains.
Results: Analysis of partial 16S rDNA sequences gave 4 well defined phylogenetic groups. Cluster
group 1 was composed of the majority of strains (170/189) and included Biogroups 1–5, 7–9, 11,
13 and 14. Cluster 3 corresponded with Biogroup 15 and cluster 4 with Biogroups 6, 10 and 12.
Cluster group 2 comprised a new Biogroup 16. For the isolates in this study, the four DNA cluster
groups can be distinguished using the inositol, dulcitol and indole tests.
Conclusion: This study demonstrates an agreement between genotyping (partial 16S rDNA) and
biotyping and describes a new biogroup of E. sakazakii.
Background
Enterobacter sakazakii is an emergent pathogen that is asso-
ciated with neonatal infection [1,2]. Most reported out-
breaks have occurred in neonatal intensive care units and
some have been linked to the ingestion of contaminated
powdered infant milk formula [3,4].
E. sakazakii was defined as a new species by Farmer et al.
1980. Using DNA-DNA hybridization the previously 'yel-
low pigmented Enterobacter cloacae' was shown to be 41–
54% related to Enterobacter and Citrobacter species. Farmer
et al. [5] described 15 biogroups of E. sakazakii based on
biochemical profiles with the wild type Biogroup 1 being
the most common. Since 1980 prokaryotic systematics
has changed with the increasing use of 16S rDNA
sequence analysis [6,7]. Harada and Ishikawa [8] used
DNA sequence analysis of the groEL operon to determine
the phylogenetic relationship among Enterobacter,  Pan-
toea, Klebsiella, Serratia and Erwinia species. Hoffmann and
Roggenkamp [9] used hsp60 (groEL homologue) DNA
sequence variation to investigate E. cloacae polyphyletic
groups. Previously, it has been shown by both partial 16S
rDNA and hsp60 gene sequencing that isolates identified
as E. sakazakii using commercial identification kits form at
least four distinct clusters [10]. Recently, an Artificial Neu-
ral Network has been published which identified key bio-
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chemical and 16S rDNA sequences that distinguish E.
sakazakii  from closely related organisms [11].
In this study, we compare the biogroups of 189 strains
with the four 16S rDNA cluster groups. We also identified
key biochemical characteristics for the differentiation of
these four genotypes. This significantly extends the previ-
ous work of Farmer et al. [5], which used five strains to
genetically define the species and a total of 57 strains to
define biogroups.
Results
Biogroups
The biochemical profiles obtained for each strain were
compared to the biogroups originally described by Farmer
et al [5]. Clinical strains were distributed among fourteen
of the biogroups (Table 1). The defining tests were motil-
ity, Voges-Proskauer, methyl red, indole, ornithine decar-
boxylase, reduction of nitrate to nitrite, production of gas
from D-glucose, malonate utilization and production of
acid from myo-inositol and dulcitol. Where strains could
not be assigned to an original biogroup, a new biogroup
or subgroup was designated (Table 2). The majority of iso-
lates (60/189) were in Biogroup 1 with the E. sakazakii
ATCC 29544T type strain. These strains were motile, pro-
duced gas from glucose, produced acid from inositol,
reduced nitrate and were positive for Voges-Proskauer and
ornithine decarboxylase, but negative for methyl red,
indole, malonate utilization and acid production from
dulcitol. Biogroup 2 (n = 42) contained isolates negative
for acid production from inositol; four of these were also
non-motile. Biogroup 3 (non-motile) contained six
strains and Biogroup 4 (ornithine negative) contained
nine strains three of which were non-motile. Biogroup 5
(n = 16) was positive for malonate utilization and six of
these were non-motile. Biogroup 6 (n = 2) was positive for
indole and Biogroup 7 (n = 4) was negative for gas pro-
duction from glucose. Biogroup 8 (n = 7) was defined by
the inability to reduce nitrate. Two of these 7 strains were
positive in the malonate test, three were negative for the
inositol test and two were inositol negative but malonate
positive. Biogroup 9 contained 13 strains that were inosi-
tol negative and malonate positive. Biogroup 10 con-
tained one strain that was inositol negative and indole
positive, while Biogroup 11 contained one strain that was
inositol negative and dulcitol positive. Biogroup 12 was
also represented by only one strain, which was indole and
malonate positive. The seven isolates in Biogroup 13 were
negative for the Voges-Proskauer reaction, three were non-
motile, one was negative for methyl red and one was neg-
ative for ornithine. Biogroup 14 (n = 5) was negative for
ornithine decarboxylase and inositol, with four of these
strains being positive for malonate. Biogroup 15 was pos-
itive for all the tests performed except methyl red. A new
group (Biogroup 16) had to be defined to accommodate
9 strains which were inositol and dulcitol positive, but
indole negative. They were malonate positive, with the
exception of one strain. Two strains were non-motile and
one of these was also ornithine decarboxylase negative.
Acid production from α-methyl-D-glucoside was
included in the original study [1] and all biogroups were
reported positive for this trait with the exception of Bio-
group 15. As Biogroup 15 could be distinguished from the
other biogroups without the α-methyl-D-glucoside test,
this was not repeated for all strains in this study.
Phylogenetic analysis
Partial 16S rDNA sequences (528 bp) containing less than
1% undetermined positions were obtained for all strains
in this study. The sequences were analysed using the max-
imum parsimony method, which is an evolutionary
model that searches for the simplest tree that can be con-
structed using the fewest inferred changes between charac-
ters. The topology was optimised using simulated
annealing, a heuristic that occasionally accepts a worse
tree during the course of the search allowing it to escape
local optima. This method is more economical than the
more usual heuristic searches (stepwise addition and hill-
climbing), which can require many randon re-starts, espe-
cially with large data matrices [12]. In agreement with pre-
vious reports [10], the isolates used in this study were
divided into four genomic groups by 16S rDNA sequence
analysis (Fig 1). The majority (170/189) of the presump-
tive E. sakazakii isolates in this study clustered with the
type strain (Fig. 1E. sakazakii cluster 1). Cluster 1 was com-
posed of the majority of biogroups, Biogroups 1–5, 7–9,
11, 13 and 14. The 9 isolates forming the new proposed
Biogroup 16 corresponded with E. sakazakii cluster 2 (Fig.
1 cluster 2), with between 1.23–1.89% 16S rDNA
sequence difference from the E. sakazakii type strain. No
strains representative of this biochemical profile were
included in the original study by Farmer et al. [5].
The six isolates in Biogroup 15 corresponded to E. sakaza-
kii cluster 3 (Fig. 1 cluster 3). The four strains described as
E. sakazakii cluster 4 (Fig. 1 cluster 4) represent Biogroups
6, 10 and 12. For this dataset, the four partial 16S rDNA
cluster groups can be distinguished biochemically using
the indole, dulcitol, and inositol tests (Table 4). Cluster 1
strains are variable for inositol, negative for indole, and
dulcitol; with the exception of Biogroup 11, which is dul-
citol positive and inositol negative. Cluster 2 – Biogroup
16 strains are positive for inositol and dulcitol but nega-
tive for indole. Cluster 3 – Biogroup 15 is positive for
inositol, dulcitol and indole. Cluster 4 strains were also
positive for indole but can be distinguished from Cluster
3 as they are negative for dulcitol. One of the strains in
Cluster 4 was inositol negative (Biogroup 10) and one was
malonate positive (Biogroup 12). There were insufficientBMC Microbiology 2006, 6:94 http://www.biomedcentral.com/1471-2180/6/94
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isolates in Cluster 4 biogroups to determine whether these
biogroups could be further genomically divided.
Discussion
Farmer et al. [5] described 15 biogroups of 57 strains of E.
sakazakii. Five strains were used to genetically define the
species by DNA-DNA hybridization and the remaining
strain definitions were phenotypic. This study defines iso-
lates in terms of both phenotype and genotype and
extends the initial 1980 [5] study with the analysis of 189
strains. According to partial 16S rDNA sequence analysis
the majority of E. sakazakii strains clustered with the type
strain (Figure 1), and within this cluster there was no clear
further genomic division corresponding to biogroup. A
second cluster of closely related strains was identified
(cluster 2) which were biochemically distinct from cluster
1 and formed a biogroup that had not been previously
described by Farmer et al [5]. These strains were not
assigned a species match using the MicroSeq 500 or sup-
plemental bacterial databases, but the nearest match was
E. sakazakii (1.23–1.89%). Biogroup 15 [5] corresponds
to E. sakazakii cluster 3, while Biogroups 6, 10 and 12 cor-
respond to E. sakazakii cluster 4 [10,11].
Analysis of the full 16S sequence of strains corresponding
to cluster groups 2 (biogroup 16) [13] and 3 (biogroup
15) [14] show these are less than 3% divergent from clus-
ter group 1. Although DNA-DNA hybridization is the
acknowledged standard for species delineation this tech-
nique was beyond the scope of this study, which focuses
on evaluation of the biogroups reported when E. sakazakii
was originally described. As well as defining a new bio-
group (with three subgroups), this study found 10 sub-
groups within the original biogroups. The malonate and
motility tests account for the majority of the subdivisions
of the original biogroups.
In this study, the majority of food isolates belonged to
Biogroups 1 and 2. All biogroups except 10 and 16 con-
tained at least one strain from a clinical source. The great-
est number of clinical strains (10 isolates) was found to
belong to Biogroup 9 (Table 1). However, this included 9
isolates out of the ten from the same hospital. Therefore
this may not be an indication of increased pathogenicity
of this biogroup, but is likely due to an over representa-
tion of one clonal type from a single source. Most of the
food isolates (including infant foods) belonged to Bio-
groups 1 and 2.
Conclusion
Biogroup 1 was the major group with approximately one
third of the E. sakazakii strains (60/189). Cluster 1 was the
major DNA cluster (170/189 strains), and was composed
of Biogroups 1–5, 7–9, 11, 13 and 14. Cluster 3 is equiv-
alent to Biogroup 15, and a new Biogroup 16 was desig-
nated for the strains in Cluster 2. For this dataset it is
possible to differentiate the four genomic clusters using
indole, dulcitol and inositol tests.
Methods
Sources of bacterial strains
A total of 189 E. sakazakii strains were analyzed in this
study. Strains were from diverse food, clinical and envi-
ronmental sources worldwide. The origin distribution of
Table 1: Origins of E. sakazakii isolates used in this study.
Biogroup Strain origin Total
Clinical Powdered infant formula and infant food Other dried food products Environmental Unknown
1 7 16 33 2 2 60
24 1 2 2 3 3 4 2
34 1 1 6
44 1 1 3 9
52 2 1 1 1 1 6
61 1 2
72 1 1 4
81 2 2 2 7
91 0 2 1 1 3
10 11
11 1 1
12 1 1
13 3 3 1 7
14 1 2 2 5
15 1 3 2 6
16 1 7 1 9
Total 42 38 89 3 17 189BMC Microbiology 2006, 6:94 http://www.biomedcentral.com/1471-2180/6/94
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the isolates is given in Table 1. At least one strain from
each of the biogroups described when the E. sakazakii spe-
cies was designated were included and representative
strains for each biogroup are given in Table 3. The type
strain (NCTC 11467T) was purchased from the NCTC,
London, UK, as were strains NCTC 9844, NCTC 9238 and
NCTC 9846. Strain NCIMB 8272 was purchased from the
NCIMB, Aberdeen, Scotland. Eleven strains, CDC 5960-
70, 1895-73, 0743-75, 3523-75, 9363-75, 9369-75, 0407-
77, 0996-77, 1058-77, 1716-77, and 3128-77 were
donated by the CDC, Atlanta, GA, USA. Strains were also
kindly donated by the following: – Nestlé Research
Center, Lausanne, Switzerland; Health Products and Food
branch, Health Canada; Children's Hospital Los Angeles
CA, USA; Northern Foods, UK; Oxoid Ltd., Basingstoke,
UK; Hospital Cèské Budéjovice, Czech Republic; Institut
fûr Tierärztliche Nahrungsmittelkunde Milchwissenschaf-
ten, Justus-Liebig-Universität Gießen, Germany; Notting-
ham City Hospital Trust, Nottingham, UK and the
Department of Medical Microbiology, Radboud,
Nijmegen, Netherlands. All other strains were food and
environmental isolates from the culture collection at Not-
tingham Trent University, Nottingham, UK.
Phenotypic characterisation
In addition to phenotypes derived from commercial bio-
chemical test kits (Microbact GN2, Oxoid; API 20E and
ID32E, BioMérieux) according to manufacturers' recom-
mendations, the following tests were performed using
conventional manual methods. Motility was determined
at 37°C after 24 and 48 h using motility medium (tryp-
tose 10 g l-1, NaCl 5 g l-1, agar 5 g l-1, pH 7.2 ± 0.2). Acid
Table 2: Assignment of strains to the biogroups originally defined by Farmer et al. [1]
Farmer Biogroup Additional group Phenotypea No. of strains 16s rDNA cluster
VP MR Nit Orn Mot Ino Dul Ind Malo Gas
1 + - + ++ + - --+ 6 0 1
2 + - + ++ - - --+ 3 8 1
2 a + - + +-- - --+ 4 1
3 + - + +- + - --+ 6 1
4 + - + -+ + - --+ 6 1
4 a + - + -- + - --+ 3 1
5+ - + + + + - - + + 1 0 1
5a + - + + - + - - + + 6 1
6+ - + + + + - + - + 2 4
7+ - + + + + - - - - 4 1
8 + - - ++ + - --+ 0 1
8 a + --++--- - + 3 1
8 b + --+++--++ 2 1
8 c + --++---++ 2 1
9+ - + + + - - - + + 1 2 1
9a - - + + + - - - + + 1 1
10 + - + + + - - + - + 1 4
1 1 +-+++-+- - + 1 1
12 + - + + + + - + + + 1 4
1 3 - + + ++ + - --+ 2 1
1 3 a - + + +- + - --+ 3 1
1 3 b - + + -+ + - --+ 1 1
1 3 c - - + ++ + - --+ 1 1
14 + - + - + - - - + + 4 1
1 4 a + - + -+ - - --+ 1 1
1 5 +-++ ++++ + + 6 3
New Biogroup 16 + - + + + + + - + + 6 2
16a + - + + - + + - + + 1 2
1 6 b + - + ++ + + --+ 1 2
16c + - + - - + + - + + 1 2
aVP, Voges-Proskauer; MR, methyl red; Nit, nitrate reduction; Orn, ornithine utilization; Mot, motility at 37°C; Ino, acid production from inositol; 
Dul, acid production from dulcitol; Ind, indole production; Malo, malonate utilization; Gas, gas production from glucose. All isolates positively 
reacted with α-methyl-D-glu, with the exception of biogroup 15 isolates.BMC Microbiology 2006, 6:94 http://www.biomedcentral.com/1471-2180/6/94
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Maximum parsimony tree (unrooted) showing the four genomic clusters of E. sakazakii based on partial 16S rDNA sequence  analysis Figure 1
Maximum parsimony tree (unrooted) showing the four genomic clusters of E. sakazakii based on partial 16S 
rDNA sequence analysis. Gaps were not considered an extra state, and the topology was optimised using simulated anneal-
ing.
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production from carbohydrates was tested in phenol red
broth base (10 g l-1 peptone, 1 g l-1 yeast extract, 5 g l-1
NaCl, 0.018 g l-1 phenol red) with the addition of filter-
sterilized carbohydrate solution (final concentration
0.5%). Gas production from D-glucose was determined
by collection in Durham tubes. Malonate utilization was
determined using sodium malonate broth (sodium
malonate 3 g l-1, ammonium sulphate 2 g l-1, bromothy-
mol blue 0.025 g l-1, NaCl 2 g l-1, yeast extract 1 g l-1, dipo-
tassium hydrogen phosphate 0.6 g l-1, potassium
dihydrogen phosphate 0.4 g l-1). The methyl red test was
performed by addition of indicator (0.1 g methyl red per
300 ml 95% ethanol) to cultures grown for 48 h in 4 ml
of MR-VP broth (VWR, 1.05712.0500). The Voges-
Proskauer test was performed by the addition of 40%
potassium hydroxide in water and 5% 1-naphthol in
(95% ethanol) to cultures grown for 24 hours in MR-VP
broth. Indole production was measured by the addition of
Table 3: Representative strains from each of the biogroups used in this study.
Biogroup NTUa strain number Source Origin
1 1 NCTC 11467b Child's throat (Type strain) (ATCC 29544 = CDC 4562-70)
2 12 Cèské Budéjovicec Faeces (adult 3753)
2a 512 Radboudd Clinical (Prague 26248)
3 680 CDC 996-77e Spinal fluid (New York, USA)
4 683 CDC 407-77 Sputum (Pennsylvania, USA)
4a 515 Radboud Clinical (Prague 26706)
5 685 CDC 1716-77 Blood (Connecticut, USA)
5a 472 NTU Infant formula (Korea)
6 564 CDC 5960-70 Blood (Florida, USA)
7 686 CDC 9369-75 Unknown
8a 22 FSM E321f Infant formula (France)
8b 15 Cèské Budéjovice Faeces (adult 2422)
8c 35 NTU Infant cereal (Washington, USA)
9 681 CDC 1058-77 Breast abscess
9a 521 Radboud Clinical (Prague 27288)
10 582 NCTC 9844 Unknown
11 684 CDC 3128-77 Sputum (Alabama, USA)
12 563 CDC 0743-75 Foot wound (Wisconsin, USA)
13 567 CDC 9363-75 Unknown
13a 535 Radboud Milk powder (New Zealand)
13b 507 Radboud Clinical (Prague 25569)
13c 101 NTU Whole mixed spice
14 565 CDC 1895-73 Faeces (Maryland, USA)
14a 33 NTU Baby rice (Herndon, USA)
15 566 CDC 3523-75 Bone marrow (Arizona, USA)
16 9 NTU Infant food (cheese puffs)
16a 92 NTU Herb (biota tops)
16b 57 NTU Milk powder (UK)
16c 581 NCTC 9529 Water
aNottingham Trent University, Nottingham, UK; bNCTC, London, UK; cHospital Cèské Budéjovice, Czech Republic; dDepartment of Medical 
Microbiology, Radboud, Nijmegen, Netherlands; eCDC, Atlanta, GA, USA; fNestlé Research Center, Lausanne, Switzerland.
Table 4: Biochemical differentiation of E. sakazakii 16S rDNA clusters.
Farmer Biogroup Phenotype a No. of strains Genomic cluster
Ino Dul Ind
1–5, 7–9, 13, 14 (+/-) - - 169 1
11 - + - 1 1
16 + + - 9 2
15 + + + 6 3
6, 10, 12 (+/-) - + 4 4
aIno, acid production from inositol; Dul, acid production from dulcitol; Ind, indole production; (+/-), some stains positive, some strains negative, the 
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Kovacs reagent (5 g p-dimethylaminobenzaldehyde, 25
ml HCl, 75 ml pentanol-1-ol) or James Reagent (70542
BioMérieux) to cultures grown for 24 h in peptone water
(CM0009 Oxoid). Nitrate reduction to nitrite was deter-
mined by the addition of 1% sulphanilamide in 1 M HCl
and 0.02% N-1 naphthylene diamine HCl in water to
nitrate test broths. Zinc dust was added to negative tubes
of nitrate-negative strains to confirm the presence of unre-
duced nitrate.
Genotypic characterisation
Comparative 16S rDNA sequencing (528 bp) was per-
formed as previously described [11] by Accugenix
(Newark, DE, USA) using the MicroSeq™ 500 16S rDNA
Bacterial Sequencing Kit (Applied Biosystems).
A maximum parsimony tree (Fig. 1) of 16S rDNA
sequences was generated using Bionumerics (Applied
Maths, Belgium). Gaps were not considered an extra state
and the topology was optimized using simulated anneal-
ing.
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